Effect of prothrombin complex concentrate on INR and blood coagulation system in emergency patients treated with warfarin overdose

Annals of Hematology

Volumn 82, Issue 2, 2003, Pages 121-123

  Yasaka, M ^a   Oomura, M ^a   Ikeno, K ^a   Naritomi, H ^a   Minematsu, K ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Blood coagulation system; International normalized ratio; Prothrombin complex concentrate; Warfarin overdose

Indexed keywords

ANTIBIOTIC AGENT; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 9A; D DIMER; PROTEIN C; PROTHROMBIN; PROTHROMBIN COMPLEX; THROMBIN ANTITHROMBIN COMPLEX; VITAMIN K GROUP; WARFARIN; BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR; PROTHROMBIN COMPLEX CONCENTRATES;

AGED; ANTICOAGULANT THERAPY; ARM; ARTICLE; BACTERIAL PNEUMONIA; BLOOD CLOTTING; CASE REPORT; DRUG OVERDOSE; EDEMA; FEMALE; HUMAN; INTERNATIONAL STANDARD UNIT; MALE; PLEURA EFFUSION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULSE WAVE; PUNCTURE; RADIAL ARTERY; SKIN BLEEDING; STROKE; BLEEDING; BLOOD; CEREBROVASCULAR ACCIDENT; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; EMERGENCY HEALTH SERVICE; HEART ATRIUM FIBRILLATION; INTERNATIONAL NORMALIZED RATIO; INTOXICATION; METHODOLOGY;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; BLOOD COAGULATION; BLOOD COAGULATION FACTORS; CEREBROVASCULAR ACCIDENT; EMERGENCY MEDICAL SERVICES; FEMALE; HEMORRHAGE; HUMANS; INTERNATIONAL NORMALIZED RATIO; OVERDOSE; WARFARIN;

EID: 0038014058     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-002-0568-y     Document Type: Article

References (12)

1. Albers GW (1994) Atrial fibrillation and stroke: three new studies, three remaining questions. Arch Intern Med 154:1443-1448
2. Butler AC, Tait RC (1998) Management of oral anticoagulant-induced intracranial haemorrhage. Blood Rev 12:35-44
3. Boulis NB, Bobek MP, Schmaier A, Hoff JT (1999) Use of factor IX complex in warfarin-related intracranial hemorrhage. Neurosurgery 45:1113-1119
4. Cartmill M, Dolan G, Byrne JL, Byrne PO (2000) Prothrombin complex concentrate for oral anticoagulant reversal in neurosurgical emergency. Br J Neurosurg 14:458-461
5. EAFT (European Atrial Fibrillation Trial) study group (1993) Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 342:1255-1262
6. Fredriksson K, Norrving B, Stromblad LG (1992) Emergency reversal of anticoagulation after intracerebral hemorrhage. Stroke 23:972-977
7. Hart RG, Sherman DG, Easton JD, Cairns JA (1998) Prevention of stroke in patients with nonvalvular atrial fibrillation. Neurology 51:674-681
8. Makris M, Graves M, Phillips WS, Kitchen S, Rosendaal FR (1997) Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy. Thromb Haemost 77:477-480
9. Marlar RA, Montgomery RR, Broekmans AW (1989) Diagnosis and treatment of homozygous protein C deficiency. J Pediatr 114:528-534
10. SPAF III Stroke Prevention in Atrial Fibrillation Investigators (1996) Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: stroke prevention in atrial fibrillation III randomized clinical trial. Lancet 348:633-638
11. Yamaguchi T for Japanese NVAF-Embolism Secondary Prevention Cooperative Study Group (2000) Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation. A multicenter prospective randomized trial. Stroke 31:817-821
12. Bertorp E (2000) Recombinant FVIIa in the treatment of warfarin bleeding. Semin Thromb Hernost 26:433-435